New hope for advanced bladder cancer patients in pfizer drug trial
NCT ID NCT07421700
Summary
This study is testing a new medicine, PF-08634404, for adults with advanced bladder cancer that has spread. It will see if the drug is safe, how well it works to control the cancer, and how the body processes it. One group will get the new drug alone, and another group will get it combined with an existing cancer medicine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.